Source

clinicaltrials.gov

1 article citing this source

AnalysisMar 21

First Epigenetic Reprogramming Therapy Enters Human Trials as Longevity Science Reaches a Clinical Turning Point

Life Biosciences began the first human trial of a cellular rejuvenation therapy using partial epigenetic reprogramming in Q1 2026, while senolytic pilot data shows safety in Alzheimer's-risk patients.

5 min read4 sources